Nicotine dependence produces hyperalgesia: Role of corticotropin-releasing factor-1 receptors (CRF1Rs) in the central amygdala (CeA)

Neuropharmacology

Volumn 77, Issue , 2014, Pages 217-223

  Baiamonte, Brandon A ^a   Valenza, Marta ^b   Roltsch, Emily A ^a   Whitaker, Annie M ^a   Baynes, Brittni B ^a   Sabino, Valentina ^b   Gilpin, Nicholas W ^a,c  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

CRF1 receptor; Hargreaves; Nicotine dependence; R121919; Withdrawal

Indexed keywords

3 (6 DIMETHYLAMINO 4 METHYL 3 PYRIDINYL) 7 DIPROPYLAMINO 2,5 DIMETHYLPYRAZOLO[1,5 A]PYRIMIDINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; MESSENGER RNA; NICOTINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVERSIVE BEHAVIOR; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; DRUG DOSE COMPARISON; EXPERIMENTAL TEST; GENE EXPRESSION; HARGREAVES TEST; HEAT STRESS; HYPERALGESIA; MALE; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; SMOKING CESSATION; TOBACCO DEPENDENCE;

CRF1 RECEPTOR; HARGREAVES; NICOTINE DEPENDENCE; R121919; WITHDRAWAL;

AMYGDALA; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; HYPERALGESIA; MALE; NICOTINE; PAIN THRESHOLD; PYRIMIDINES; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

EID: 84886562916     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.09.025     Document Type: Article

References (62)

1. K.L. Anderson, K.E. Pinkerton, D. Uyeminami, C.T. Simons, M.I. Carstens, and E. Carstens Antinociception induced by chronic exposure of rats to cigarette smoke Neurosci. Lett. 366 1 2004 86 91 (Pubitemid 38953154)
2. L. Arborelius, M. Owens, P. Plotsky, and C. Nemeroff The role of corticotropin-releasing factor in depression and anxiety disorders J. Endocrinol. 160 1999 1 10
3. C. Aydin, O. Oztan, and C. Isgor Effects of a selective Y2R antagonist, JNJ-31020028, on nicotine abstinence-related social anxiety-like behavior, neuropeptide Y and corticotropin releasing factor mRNA levels in the novelty-seeking phenotype Behav. Brain Res. 222 2011 332 341
4. T.L. Bale, and W.W. Vale CRF and CRF receptors: role in stress responsivity and other behaviors Annu. Rev. Pharmacol. Toxicol. 44 2004 525 557 (Pubitemid 38263852)
5. P.L. Brennan, K.K. Schutte, and R.H. Moos Pain and use of alcohol to manage pain: prevalence and 3-year outcomes among Addiction 100 6 2005 777 786
6. A. Bruijnzeel Tobacco addiction and the dysregulation of brain stress systems Neurosci. Biobehav. Rev. 36 5 2012 1418 1441
7. A.W. Bruijnzeel, M. Prado, and S. Isaac Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse Biol. Psychiatry 66 2 2009 110 117
8. A. Bruijnzeel, J. Ford, J.A. Rogers, S. Scheick, Y. Ji, M. Bishnoi, and J.C. Alexander Blockade of CRF1 receptors in the central nucleus of the amygdala attenuates the dysphoria associated with nicotine withdrawal in rats Pharmacol. Biochem. Behav. 101 1 2012 62 68
9. D.H. Brunzell, D.S. Russell, and M.R. Picciotto In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57Bl/6J mice J. Neurochem. 84 2003 1431 1441 (Pubitemid 36343609)
10. 1 receptor dependent increase in anxiety-like behavior and hyperalgesia in rats Addict. Biol. 2013 10.1111/adb.12077 (July 22, Epub ahead of print)
11. S. Edwards, L.F. Vendruscolo, J.E. Schlosburg, K.K. Misra, S. Wee, and P.E. Park Development of mechanical hypersensitivity in rats during heroin and ethanol Neuropharmacology 62 2 2012 1142 1151
12. M. Egli, G.F. Koob, and S. Edwards Alcohol dependence as a chronic pain disorder Neurosci. Biobehav. Rev. 36 10 2012 2179 2192
13. J.B. Fertig, O.F. Pomerleau, and B. Sanders Nicotine-produced antinociception in minimally deprived smokers and ex-smokers Addict. Behav. 11 3 1986 239 248 (Pubitemid 16058028)
14. C.K. Funk, L.E. O'Dell, E.F. Crawford, and G.F. Koob Corticotrophin- releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol dependent rats J. Neurosci. 26 2006 11324 11332 (Pubitemid 44772162)
15. C.K. Funk, E.P. Zorrilla, M.-J. Lee, K.C. Rice, and G.F. Koob Corticotrophin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats Biol. Psychiatry 61 1 2007 78 86 (Pubitemid 44855743)
16. O. George, S. Ghozland, M.R. Azar, P. Cottone, E.P. Zorrilla, and L.H. Parsons CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats Proc. Natl. Acad. Sci. 104 43 2007 17198 17203 (Pubitemid 350211014)
17. N.W. Gilpin, A.M. Whitaker, B. Baynes, A.Y. Abdel, M.T. Weil, and O. George Nicotine vapor inhalation escalates nicotine self-administration Addict. Biol. 2013 10.1111/adb.12021
18. S.D. Grabus, B.R. Martin, A.M. Batman, R.F. Tyndale, E. Sellers, and M. Imad Damaj Nicotine physical dependence and tolerance in the mouse following chronic oral administration Psychopharmacology 178 2 2005 183 192 (Pubitemid 40379213)
19. T.S. Gray, and D.J. Magnuson Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat Peptides 13 3 1992 451 460
20. M. Heilig, G.F. Koob, R. Ekman, and K.T. Britton Corticotrophin-releasing factor and neuropeptide Y: role in emotional integration Trends Neurosci. 17 2 1994 80 85 (Pubitemid 24033179)
21. J.E. Henningfield, and G.S. Zaatari Electronic nicotine delivery systems: emerging science foundation for policy Tob. Control 19 2 2010 89 90
22. C.S. Hubbard, J.S. Labus, J. Bueller, J. Stains, B. Suyenobu, and G.E. Dukes Corticotropin-releasing factor receptor 1 antagonist alters regional activation and effective connectivity in an emotional-arousal circuit during expectation of abdominal pain J. Neurosci. 31 35 2011 12491 12500
23. J.R. Hughes, and D. Hatsukami Signs and symptoms of tobacco withdrawal Arch. Gen. Psychiatry 43 3 1986 289 294 (Pubitemid 16052281)
24. M. Hummel, T. Cummons, P. Lu, L. Mark, J.E. Harrison, J.D. Kennedy, and G.T. Whiteside Pain is a salient "stressor" that is mediated by corticotropin-releasing factor-1 receptors Neuropharmacology 59 2010 160 166
25. S. Ide, T. Hara, A. Ohno, R. Tomano, K. Koseki, and T. Naka Opposing roles of corticotropin-releasing factor and neuropeptide Y within the dorsal bed nucleus of the stria terminalis in the negative affective component of pain in rats J. Neurosci. 33 14 2013 5881 5894
26. K.J. Jackson, F.I. Caroll, S.S. Negus, and M.I. Damaj Effect of selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse Psychopharmacology (Berl.) 210 2 2010 285 294
27. G. Ji, and V. Neugebauer Pro- and anti-nociceptive effects of corticotropin-releasing factor (CRF) in central amygdala neurons are mediated through different receptors J. Neurophysiol. 102 2008 2253 2264
28. G. Ji, Y. Fu, K.A. Ruppert, and V. Neugebauer Pain-related anxiety-like behavior requires CRF1 receptors in the amygdala Mol. Pain 3 13 2007 10.1186/1744-8069-3-13 (Pubitemid 46939473)
29. R.-R. Ji, R.W. Gereau IV, M. Malcangio, and G.R. Strichartz MAP kinase and pain Brain Res. Rev. 60 2009 135 148
30. G. Ji, Y. Fu, H. Adwanikar, and V. Neugebauer Non-pain-related CRF1 activation in the amygdala facilitates the synaptic transmission and pain responses Mol. Pain 9 2 2013 10.1186/1744-8069-9-2
31. J.P. Johansen, J.W. Tarpley, J.E. LeDoux, and H.T. Blair Neural substrates for expectation-modulated fear learning in the amygdala and periaqueductal gray Nat. Neurosci. 13 8 2010 979 986
32. G.F. Koob A role for brain stress systems in addiction Neuron 59 1 2008 11 34 (Pubitemid 351905857)
33. G.F. Koob The role of CRF and CRF-related peptides in the dark side of addiction Brain Res. 1314 2010 3 14
34. G.F. Koob, A. Markou, F. Weiss, and G. Schulteis Opponent process and drug dependence: neurobiological mechanisms Semin. Neurosci. 5 1993 351 358 (Pubitemid 23322891)
35. C.A. Marcinkiewcz, M.M. Prado, S.K. Isaac, A. Marshall, D. Rylkova, and A.W. Bruijnzeel Corticotrophin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats Neuropsychopharmacology 34 7 2009 1743 1752
36. A. Markou Neurobiology of nicotine addiction Phil. Trans. R. Soc. B 363 2008 3159 3168
37. A. Markou, T.R. Kosten, and G.F. Koob Neurobiological similarities in depression and drug dependence: a self-medication hypothesis Neuropsychopharmacology 18 1998 135 174 (Pubitemid 28062580)
38. Q.Y. Meng, X.N. Chen, D.L. Tong, and J.N. Zhou Stress and glucocorticoids regulated corticotropin releasing factor in rat prefrontal cortex Mol. Cell. Endocrinol. 342 1-2 2011 54 63
39. B. Myers, and B. Greenwood-Van Meerveld Elevated corticosterone in the amygdala leads to persistent increases in anxiety-like behavior and pain sensitivity Behav. Brain Res. 214 2 2010 465 469
40. T. Oka, T. Tsumori, S. Yokota, and Y. Yasui Neuroanatomical and neurochemical organization of projections from the central amygdaloid nucleus to the nucleus retroambiguus via the periaqueductal gray in the rat Neurosci. Res. 62 4 2008 286 298
41. M.A. Oliveira, and W.A. Prado Role of PAG in the antinociception evoked from the medial or central amygdala in rats Brain Res. Bull. 54 1 2001 55 63 (Pubitemid 32156916)
42. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates fourth ed. 1998 Academic Press San Diego, CA
43. M.E. Piper, S.S. Smith, T.R. Schlam, M.F. Fleming, A.A. Bittrich, and J.L. Brown Psychiatric disorders in smokers seeking treatment for tobacco dependence J. Consult. Clin. Psychol. 78 1 2010 13 23
44. O.F. Pomerleau, D.C. Turk, and J.B. Fertig The effects of cigarette smoking on pain and anxiety Addict. Behav. 9 3 1984 265 271 (Pubitemid 14062005)
45. D.V. Reynolds Surgery in the rat during electrical analgesia induced by focal brain stimulation Science 164 1969 444 445
46. H.N. Richardson, Y. Zhoa, E.M. Fekete, C.K. Funk, P. Wirsching, and K.D. Janda MPZP: a novel small molecule corticotrophin-releasing factor type 1 receptor (CRF1)antagonist Pharmacol. Biochem. Behav. 88 4 2007 497 510
47. J.L. Riley 3rd, and C. King Self-report of alcohol use for pain in a multi-ethnic community sample J. Pain 10 9 2009 944 952
48. V. Risbrough Role of corticotropin releasing factor in anxiety disorders: a translational research perspective 50 4 2006 550 561
49. T.A. Rizvi, M. Ennis, M.M. Behbehani, and M.T. Shipley Connections between the central nucleus of the amygdala and the midbrain periaqueductal gray: topography and reciprocity J. Comp. Neurol. 303 1 1991 121 131
50. M. Roberto, M.T. Cruz, N.W. Gilpin, V. Sabino, P. Schweitzer, and M. Bajo Corticotrophin releasing factor-induced amygdala gamma-aminobutyric acid release plays a key role in alcohol dependence Biol. Psychiatry 67 9 2010 831 839
51. T. Rouwette, P. Vanelderen, E.W. Roubos, T. Kozicz, and K. Vissers The amygdala, a relay station for switching on and off pain Eur. J. Pain 16 6 2012 782 792
52. J.D. Shepard, K.W. Barron, and D.A. Myers Corticosterone delivery to the amygdala increases corticotropin-releasing factor mRNA in the central amygdaloid nucleus and anxiety-like behavior Brain Res. 861 2 2000 288 295 (Pubitemid 30173314)
53. O.V. Torres, L.G. Gentil, L.A. Natividad, L.M. Carcoba, and L.E. O'Dell Behavioral, biochemical, and molecular indices of stress are enhanced in female versus male rats experiencing nicotine withdrawal Front. Psychiatry 4 2013 38
54. L. Tran, and B. Greenwood-Van Meerveld Altered expression of glucocorticoid receptor and corticotropin-releasing factor in the central amygdala in response to elevated corticosterone Behav. Brain Res. 234 2 2012 380 385
55. H.L. Tripathi, B.R. Martin, and M.D. Aceto Nicotine-induced antinociception in rats and mice: correlation with nicotine brain levels J. Pharmacol. Exp. Ther. 221 1 1982 91 96 (Pubitemid 12156477)
56. A. Trtchounian, and P. Talbot Electronic nicotine delivery systems: is there a need for regulation? Tob. Control 20 2011 47 52
57. D.C. Turk, K.S. Swanson, and R.J. Gatchel Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis Clin. J. Pain 24 2008 497 508
58. G.R. Valdez, A.J. Roberts, K. Chan, H. Davis, M. Brennan, E.P. Zorrilla, and G.F. Koob Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotrophin-releasing factor Alcohol. Clin. Exp. Res. 26 10 2002 1494 1501 (Pubitemid 35192310)
59. G.R. Valdez, E.P. Zorrilla, J. Rivier, W.W. Vale, and G.F. Koob Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type-2 corticotropin-releasing factor agonist Brain Res. 980 2003 206 212 (Pubitemid 36829440)
60. W. Xu, T. Lundeberg, Y.T. Wang, and L.C. Yu Antinociceptive effect of calcitonin gene-related peptide in the central nucleus of the amygdala: activating opioid receptors through amygdala-periaqueductal gray pathway Neuroscience 118 4 2003 1015 1022 (Pubitemid 36561189)
61. C.Y. Yang, W.H. Wu, and V.K. Zbuzek Antinociceptive effect of chronic nicotine and nociceptive effect of its Psychopharmacology 106 3 1992 417 420
62. G. Zislis, T.V. Desai, M. Prado, H.P. Shah, and A.W. Bruijnzeel Effects of the CRF antagonist D-Phe CRF (12-41) and the alpha2-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking behavior in rats Neuropharmacology 53 8 2007 958 966 (Pubitemid 350137393)